IDPH--Positive preliminary results for pivotal trial of ID Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bill Harmond who wrote (343)	2/8/1997 4:35:00 PM
From: I. Luttichuys	of 1762

Thanks for the data William, I think the figure on Stocksmart represents a change upwards (unless, of course, they are wrong). I believe the 12 month $40 target has been around long enough now that IDEC should have almost already been there! The growth looks pretty impressive. I've said it more than once and I'll say it again: a working immunoconjugate is something the market (and the scientific community) has been waiting for for years. I believe the day is soon coming that the market will realize its here. That day is going to change the valuation of this stock for sure. Until then, I hold my shares with the tightest of fists :o). Please post anytime you may have something to share. Your experience will make you most welcome. Hope you are having a good day, BENNETT PS: I believe Morgan Stanley has used somewhat conservative estimates for these projections if I recall correctly. Brad, who is a regular poster here, has discussed this fact before some time back. If these figures are the same as those he viewed, there is room for surprise.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next